Addressing uncertainty in medical cost-effectiveness analysis implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research.

This paper examines the objectives for performing sensitivity analysis in medical cost-effectiveness analysis and the implications of expected utility maximization for methods to perform such analyses. The analysis suggests specific approaches for optimal decision making under uncertainty and specifying such decisions for subgroups based on the ratio of expected costs to expected benefits, and for valuing research using value of information calculations. Though ideal value of information calculations may be difficult, certain approaches with less stringent data requirements may bound the value of information. These approaches suggest methods by which the vast cost-effectiveness literature may help inform priorities for medical research.

[1]  D. Cutler,et al.  Measuring the Health of the U.S. Population , 1997 .

[2]  J Hornberger,et al.  A cost-benefit analysis of a cardiovascular disease prevention trial, using folate supplementation as an example. , 1998, American journal of public health.

[3]  A H Briggs,et al.  Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  H. Raiffa,et al.  Introduction to Statistical Decision Theory , 1996 .

[5]  V. Fuchs.  The health sector's share of the gross national product. , 1990, Science.

[6]  M. Mcgrath.  Cost Effectiveness in Health and Medicine. , 1998 .

[7]  D. McKusick,et al.  The next ten years of health spending: what does the future hold? The Health Expenditures Projection Team. , 1998, Health affairs.

[8]  A. Tversky,et al.  Prospect theory: analysis of decision under risk , 1979 .

[9]  Gordon B. Hazen,et al.  Sensitivity Analysis and the Expected Value of Perfect Information , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[10]  M. Johannesson,et al.  Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and Medicine , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[11]  Bernie J. O'Brien,et al.  In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care , 1994, Medical care.

[12]  A. Mushlin,et al.  Focusing Technology Assessment Using Medical Decision Theory , 1988, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  A. Tversky,et al.  Prospect Theory : An Analysis of Decision under Risk Author ( s ) : , 2007 .

[14]  Kimbroe J. Carter,et al.  Treatment of Early-Stage Breast Cancer in the Elderly , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[15]  A. Elixhauser,et al.  Health care CBA and CEA from 1991 to 1996: an updated bibliography. , 1998, Medical care.

[16]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[17]  John Mullahy,et al.  Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis , 1998 .

[18]  L. A. Goodman,et al.  Social Choice and Individual Values , 1951 .

[19]  Joseph P. Newhouse,et al.  Does More Intensive Treatment of Acute Myocardial Infarction in the Elderly Reduce Mortality? Analysis Using Instrumental Variables , 1995 .

[20]  David O. Meltzer,et al.  Accounting for future costs in medical cost-effectiveness analysis. , 1997 .

[21]  K. Arrow,et al.  Uncertainty and the Evaluation of Public Investment Decisions , 2014 .

[22]  M Johannesson,et al.  A Note on Confidence Intervals in Cost-Effectiveness Analysis , 1998, International Journal of Technology Assessment in Health Care.

[23]  Kevin M. Murphy,et al.  The Economic Value of Medical Research , 2000 .

[24]  J. Newhouse,et al.  Medical care costs: how much welfare loss? , 1992, The journal of economic perspectives : a journal of the American Economic Association.

[25]  P. Wakker,et al.  Confidence intervals for cost/effectiveness ratios. , 1995, Health economics.

[26]  J. J. Linehan,et al.  SCREENING FOR CERVICAL CANCER , 1974 .

[27]  E B Keeler,et al.  Does free care improve adults' health? Results from a randomized controlled trial. , 1983, The New England journal of medicine.

[28]  G. Chapman,et al.  [Medical decision making]. , 1976, Lakartidningen.

[29]  M J Al,et al.  Sample size calculation in economic evaluations. , 1998, Health economics.

[30]  John C. Hershey,et al.  Carrier Screening for Cystic Fibrosis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  K Claxton,et al.  An economic approach to clinical trial design and research priority-setting. , 1996, Health economics.

[32]  H. Raiffa,et al.  Applied Statistical Decision Theory. , 1961 .

[33]  D Polsky,et al.  Confidence intervals for cost-effectiveness ratios: a comparison of four methods. , 1997, Health economics.

[34]  Howard Raiffa,et al.  Applied Statistical Decision Theory. , 1961 .

[35]  A A Stinnett,et al.  Estimating CE Ratios under Second-order Uncertainty , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.